Zobrazeno 1 - 10
of 114
pro vyhledávání: '"V., BALAMURALIDHARA"'
Autor:
Sastri, K. Trideva, Gupta, N. Vishal, Kannan, Anbarasu, Dutta, Suman, Ali M Osmani, Riyaz, V, Balamuralidhara, Ramkishan, A., S, Shanmuganathan
Publikováno v:
In European Journal of Pharmacology 15 December 2024 985
Autor:
R.S., Abinesh, R., Madhav, Sastri, K. Trideva, G.S., Meghana, A.R., Akhila, V., Balamuralidhara
Publikováno v:
In Life Sciences 1 December 2024 358
Publikováno v:
Journal of Health & Allied Sciences NU; Jan2024, Vol. 14 Issue 1, p1-10, 10p
Publikováno v:
Journal of International Research in Medical and Pharmaceutical Sciences. :26-34
Brazil, which has the most people of any country in South America, just overtook India to become the country with the second-largest pharmaceutical sector in the entire globe. The National Health Surveillance Agency of Brazil, also known as Agência
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad141693fb0b88c12968da86b26cb61c
https://doi.org/10.56557/jirmeps/2022/v17i17761
https://doi.org/10.56557/jirmeps/2022/v17i17761
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Indian Journal of Pharmaceutical Education & Research; Oct-Dec2023, Vol. 57 Issue 4, p1208-1218, 11p
Autor:
Akhilesh Akki, M. P. Gowrav, Vishakharaju Motupalli, M. P. Venkatesh, V. Balamuralidhara, S. Narmada
Publikováno v:
Journal of Pharmaceutical Research International. :276-288
Pharmacovigilance is a tool proposed during the post-marketing process of the pharmaceutical product lifecycle to monitor drug safety in everyday life and to identify adverse drug reactions. The identification of adverse reactions, however, is a sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7aa2e9b6645599a23719023761cdd69
https://doi.org/10.9734/jpri/2021/v33i46a32867
https://doi.org/10.9734/jpri/2021/v33i46a32867
Publikováno v:
Journal of Pharmaceutical Research International. :438-450
Adaptation towards digitalization in pharmaceuticals leads to the utilization and development of Artificial Intelligence (AI). Significantly it is reducing human workload with the help of an algorithm. Already AI is acting as a key in clinical trial,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72bfb71b5f634043970ddfcd34309be9
https://doi.org/10.9734/jpri/2021/v33i43b32573
https://doi.org/10.9734/jpri/2021/v33i43b32573
Autor:
M. S., JYOTHI1 jyothimarike@gmail.com, V., BALAMURALIDHARA2 baligowda@jssuni.edu.com, S., NAGARAJU1
Publikováno v:
International Journal of Pharmaceutical Research (09752366). 2020 Supplement1, p1957-1965. 9p.